Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109876 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A NA study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00109876 is a NA study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 54 participants.
The verdict
NCT00109876, a NA study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well radiofrequency ablation works in treating patients with stage IA non-small cell lung cancer. Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Computed tomography (CT)-guided radiofrequency ablation may be a better treatment for non-small cell lung cancer.
Interventions
- PROCEDURE Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109876
The ClinicalTrials.gov registry entry for NCT00109876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation is the first listed.
NCT00109876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109876 about?
NCT00109876 is a clinical study titled "Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer". This pilot clinical trial studies how well radiofrequency ablation works in treating patients with stage IA non-small cell lung cancer. Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Computed tomography (CT)-guided radiofrequency ablation may be a better treatment ...
What is the current status of trial NCT00109876?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2006-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00109876?
The interventions under investigation include: Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00109876?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.